Skip to main content

Table 7 Human diseases and yeast phenotypic changes that co-occur at domain sites

From: A protein domain-centric approach for the comparative analysis of human and yeast phenotypically relevant mutations

Human Disease

Yeast Phenotypic Change

Number of Co-occurrences

Wilson's disease (WD) (OMIM:277900)

Gain of function; metal resistance: increased (PMID: 10743563)

6 (p-value: 2e-14)

Hereditary non-polyposis colorectal cancer type 2 (OMIM:609310)

Mutation frequency: increased (PMID: 16492773)

5 (p-value: 1e-13)

Susceptibility to Breast-Ovarian Cancer, Familial (OMIM:604370)

Reduction of function; protein/peptide accumulation: increased (PMID: 10218484)

4 (p-value: 4e-11)

Nemaline myopathy type 3 (OMIM: 161800)

Conditional; protein/peptide modification: absent (PMID: 16221887)

4 (p-value: 4e-11)

Familial hyperinsulinemic hypoglycemia type 1 (OMIM: 256450)

Reduction of function; replicative lifespan: decreased (PMID: 21931558)

8 (p-value: 1e-10)

Costello syndrome (OMIM:190020)

Inviable (PMID:17443350)

6 (p-value: 1e-09)

Methemoglobinemia, type 1 (OMIM:250800)

Reduction of function; heat sensitivity: increased (PMID: 19194512)

4 (p-value: 8e-09)

Crouzon syndrome (OMIM: 123500)

Resistance to chemicals: decreased (PMID: 17237519)

6 (p-value: 8e-09)

Kallman syndrome 2 with bimanual synkinesia (OMIM: 136350)

Resistance to chemicals: increased (PMID: 1715094)

4 (p-value: 4e-08)

Friedreich Ataxia (OMIM: 229300)

Protein activity: decreased (PMID: 19884169)

3 (p-value: 1e-06)

  1. The top ten yeast phenotypic changes and human diseases that have a significant overlap at the domain level as determined by Fisher's exact test. Each disease co-occurrence is counted only once for each uniquely mapping mutation to avoid overestimation due to domain model redundancy.